Singapore markets closed

Bolt Biotherapeutics, Inc. (BOLT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7500+0.0024 (+0.32%)
At close: 04:00PM EDT
0.7313 -0.02 (-2.49%)
After hours: 06:21PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
11,324
7,876
5,729
1,260
231
-
Operating expenses
Research development
63,446
61,542
73,123
75,655
40,357
-
Selling general and administrative
22,751
22,530
22,927
18,393
9,056
-
Total operating expenses
86,197
84,072
96,050
94,048
49,413
-
Operating income or loss
-74,873
-76,196
-90,321
-92,788
-49,182
-
Total other income/expenses net
-
-
-
-6,084
-11,745
-42
Income before tax
-63,028
-69,197
-88,098
-98,591
-60,728
-
Income from continuing operations
-63,028
-69,197
-88,098
-98,591
-60,728
-
Net income
-63,028
-69,197
-88,098
-98,591
-60,728
-
Net income available to common shareholders
-63,028
-69,197
-88,098
-98,591
-60,728
-
Basic EPS
-1.89
-
-2.36
-2.97
-1.91
-2.18
Diluted EPS
-1.89
-
-2.36
-2.97
-1.91
-2.18
Basic average shares
37,715
-
37,358
33,197
31,847
13,991
Diluted average shares
37,715
-
37,358
33,197
31,847
13,991